Prostate Cancer
Depression related to (neo)adjuvant hormonal therapy for prostate cancer - Abstract
February 25, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Management of castration-resistant prostate cancer after initial chemotherapy - Session Highlights
February 25, 2011
The pattern of prostate cancer local recurrence after radiation and salvage cryoablation - Abstract
February 24, 2011
Expression of leukemia/lymphoma related factor (LRF/Pokemon) in human benign prostate hyperplasia and prostate cancer - Abstract
February 24, 2011
Novel approaches and future directions in castration-resistant prostate cancer - Abstract
February 24, 2011
Prostate cancer does not influence androgen levels: A radical prostatectomy cohort study - Abstract
February 24, 2011
Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapy - Abstract
February 24, 2011
Nutritional aspects of primary prostate cancer prevention - Abstract
February 24, 2011
GU Cancers Symposium 2011: ASCO ASTRO SUO - Initial report of RTOG 9601, a phase III trial in prostate cancer - Session Highlights
February 24, 2011
Abiraterone acetate, a novel adrenal inhibitor in metastatic castration-resistant prostate cancer - Abstract
February 23, 2011
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer - Abstract
February 23, 2011
Testicular metastases from prostate cancer - Abstract
February 23, 2011
Cost-effectiveness of prostate specific antigen screening in the United States: Extrapolating from the European Study of Screening for Prostate Cancer - Abstract
February 22, 2011
Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer - Abstract
February 22, 2011